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Introduction
In 1962, the National Institutes of Health dedicated the
first Primate Center in the United States, located in Bea-
verton, Oregon and closely associated with what was then
called the University of Oregon Medical School, now
known as Oregon Health & Science University. Within a
few years, the Oregon Regional Primate Research Center
was followed by 6 others in various cities across the coun-
try that were affiliated with many distinguished universi-
ties. In recent years another institution has joined the
unique "club" now known as the National Primate Cent-
ers. The key aim of these centers was to explore the biol-
ogy of nonhuman primates with the ultimate goal of
improving human health. The original planners at NIH
who conceived the Primate Centers deserve great credit,
and this symposium is in part a testament to their fore-
sight.
While no animal model is perfect, all agree that nonhu-
man primates are superbly useful for probing key aspects
of human biological systems. Early on it was recognized
that the reproductive system in female nonhuman pri-
mates was almost identical to that of women. Conse-
quently, the Oregon Center focused its efforts on
reproductive physiology. Evidence accumulated that
numerous gynecological problems that afflict women
such as premature birth, pelvic disorders, dysfunctional
bleeding and endometriosis had their counterparts in
female nonhuman primates. Consequently, strong collab-
orations developed between Primate Center scientists and
Ob-Gyn physicians, nationally and internationally, to
probe the mechanisms underlying these disorders. Many
of the papers presented at this symposium provide sum-
maries of such collaborative efforts, and all the reviews
provide helpful perspectives and important insights into
the field of endometrial physiology, with examples drawn
from both human and nonhuman primates.
Cellular and molecular regulation of the primate 
endometrium: A perspective
Leading off, Dr. William Okulicz, Ph.D. Associate Profes-
sor, Department of Obstetrics and Gynecology, University
of Massachusetts Medical School, Worcester, MA, pro-
vided an insightful, historical review of our knowledge of
the uterus, entitled: "Cellular and molecular regulation of
the primate endometrium: A perspective". Beginning with
Aristotle's' writings in which the human uterus was erro-
neously described as bicornuate, through the 15th century
when Da Vinci and Vesalius made accurate drawings
based on autopsy specimens, Dr. Okulicz summarized the
early foundations of uterine biology. Further, he high-
lighted the work of Allen, Doisy, Corner and Markee in
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the early 1900's; pioneers whose classic experiments with
nonhuman primates revealed that endometrial cycles
were controlled by estrogens and progestins. The discov-
ery of a high affinity estradiol receptor by Elwood Jensen's
lab, the subsequent development of specific antibodies to
many receptors, and the use of immunocytochemistry to
localize hormonally sensitive cells in complex tissues were
succinctly presented. Finally, Professor Okulicz concluded
his historical review with an up to date presentation of
how microarray and subtractive hybridization can be used
to evaluate cyclic changes in gene expression in the
macaque endometrium.
Application of functional genomics to primate 
endometrium: Insights into biological processes
Dr. Linda Giudice, M.D, Ph.D., Professor and Chair of the
Department of Obstetrics, Gynecology and Reproductive
Sciences, University of California, San Francisco, CA, car-
ried the theme of global analysis of gene expression into
the realm of human endometrial physiology in her pres-
entation: "Application of functional genomics to primate
endometrium: Insights into biological processes". While
warning of the difficulties of obtaining "normal" human
endometrial specimens, she summarized the recent litera-
ture, including her own pioneering work, and suggested
that the Noyes histological dating techniques, well known
to be highly variable and observer-dependent, can now be
complemented and will eventually be replaced by stage-
specific patterns of gene expression based on microarray
and bioinformatic analysis. She characterized the
endometrium as "the anatomic prerequisite of the contin-
uation of the species" and indicated that a full, functional
genomic and proteomic analysis of this dynamic tissue is
within our grasp. By including a series of very well
designed figures and tables, she summarized in pictorial
form the regulation of specific genes during each phase of
the human endometrial cycle. Moreover, she segregated
these genes into metabolic, angiogenic, immune and
other functional classes in highly original and useful
ways. Researchers who use genomic and proteomic
approaches to explore endometrial physiology will be
well served by this succinct and brilliant review.
Regulation of human endometrial function: 
Mechanisms relevant to uterine bleeding
Hilary O.D. Critchley, Professor of Reproductive Medi-
cine, New Royal Infirmary, and Centre for Reproductive
Biology, University of Edinburgh, Edinburgh, Scotland
focused on a key phase of the human menstrual cycle,
namely, menstruation itself, in her presentation: "Regula-
tion of human endometrial function: Mechanisms rele-
vant to uterine bleeding". She noted that "...disorders of
the menstrual process are one of the banes of modern
women", and emphasized that an understanding of the
normal menstrual process at a molecular level is essential
to the development of rational therapies for the bleeding
disorders so often seen in the clinic. She identified proges-
terone withdrawal as the key precipitating factor in the
complex cascade of events that result in menstrual break-
down, and she reviewed the role of steroid receptors, ster-
oid metabolizing enzymes, hypoxia inducing factors,
matrix metalloproteinases and inflammatory mediators
in menstrual induction. She emphasized that menstrua-
tion consists of two phases, a set of early events, including
vasoconstriction of the spiral arteries, likely to be reversi-
ble, and a set of later, nonreversible events involving pro-
teolysis of the extracellular matrix and ultimate sloughing.
Her summary included a comprehensive diagram depict-
ing a modern synthesis of each step in the menstrual cas-
cade, from vasoconstriction through proteolytic
destruction. Her review made clear that further research
on the underlying details of the menstrual cascade will
greatly benefit the health of women.
A critical period of progesterone withdrawal 
precedes menstruation in macaques
Dr. Ov D. Slayden, Ph.D., Scientist, Division of Reproduc-
tive Sciences, Oregon National Primate Research Center,
Beaverton, OR, expanded on the theme that menstruation
is a two phase process in his presentation entitled: "A crit-
ical period of progesterone withdrawal precedes menstru-
ation in macaques". He induced artificial menstrual cycles
in ovariectomized macaques by sequential insertion and
removal of subcutaneous implants of estradiol (E) and
progesterone (P). When P was withdrawn at the end of the
cycle, there was approximately a 36 hour time window
during (but not after) which, menstruation could be
blocked by adding back P. After ~36 h, menstruation
became inevitable. Dr. Slayden described the effects of P
withdrawal and P add back on the regulation and locali-
zation of various matrix metalloproteinases in the pre-
menstrual and menstrual macaque endometrium, and
provided a succint summary of the literature on the poten-
tial roles of NFκB, its inhibitor, IκB, and the various
enzymes involved in regulation of endometrial prostag-
landins and cytokines. These latter factors may be the ones
that provide the initial anoxic insult that follows P with-
drawal. The work provides convincing experimental evi-
dence confirming the view that menstruation is a two-
phase process.
A baboon model of endometriosis: implications 
for fertility
Dr. Asgi Fasleablas, Ph.D., Professor of Physiology and
Director, Center for Women's Health & Reproduction,
Department of Obstetrics and Gynecology, University of
Illinois, Chicago, Ill, introduced the problem of endome-
triosis by presenting: " A baboon model of endometriosis:
implications for fertility". Although women and nonhu-
man primates are the only species in which endometriosisReproductive Biology and Endocrinology 2006, 4(Suppl 1):S2
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occurs naturally, there have been numerous attempts to
model this disease through transplantation and other
techniques in laboratory rodents. However, the absence of
cyclical menstrual breakdown in these animal models
limits their value. The experimental animals of choice for
study of endometriotic growths are the nonhuman pri-
mates, and Dr. Fasleabas' laboratory has developed and
used techniques for transplanting the menstrual
endometrium into peritoneal sites under laparoscopic
control, and for sampling both the eutopic and ectopic tis-
sues for analysis. He reviewed both his findings and the
general literature in the field, and noted that matrix met-
alloproteinases (MMPs), proteolytic enzymes that are
usually suppressed in the luteal phase, are upregulated
during the secretory phase in both the ectopic endometri-
otic and the eutopic endometrial samples, indicating
crosstalk between the two sites. He emphasized that the
high levels of MMPs present in endometrial fragments
during retrograde menstruation facilitate implant inva-
siveness. The role of angiogenic factors, including VEGF
and CYR61, in endometriotic growth, and of other factors
associated with diminished fertility were critically pre-
sented. Finally, Dr. Fasleabas discussed the "chicken vs
egg" problem, namely, whether the aberrant properties of
the eutopic endometrium are inherent (and came first) or
whether they are secondarily induced by the disease. His
working hypothesis is that peritoneal endometriotic
lesions can induce changes in the eutopic endometrium
through communication pathways that are currently
unknown and need to be elucidated. Students of endome-
triosis will benefit in important ways from this scholarly
review.
Role of nonhuman primate models in the 
discovery and clinical development of selective 
progesterone receptor modulators (SPRMs)
Dr. Kristof Chwalisz, M.D., Ph.D., Therapeutic Area Head
of Women's Health at TAP Pharmaceutical Products, Inc.,
Chicago, III, addressed new ways to treat human endome-
triosis in his presentation entitled: "Role of nonhuman
primate models in the discovery and clinical development
of selective progesterone receptor modulators (SPRMs)".
These molecules, in his words, "represent a new class of
PR ligands that exert clinically relevant tissue-selective
progesterone agonist, antagonist, partial, or mixed ago-
nist/antagonist effects on... progesterone target tissues... ".
These remarkable compounds have an equally remarka-
ble history. The field began with the discovery of progestin
antagonists, typified by RU 486, at Roussel-UCLAF in
1981. Subsequently, Walter Elger at Jenapharm GmbH
(Jena, Germany) discovered a new class of mixed agonist-
antagonists, called mesoprogestins because they func-
tioned "midway" between progestins and antiprogestins;
these molecules have been renamed SPRMs. Dr. Chwalisz
reviewed the clinical studies his group conducted which
clearly demonstrated the value of these compounds in the
treatment of endometriosis as well as leiomyoma and dys-
functional bleeding. In addition, he summarized preclin-
ical studies in nonhuman primates which showed that
SPRMs had endometrial antiproliferative effects. The non-
human primate studies, he noted "...played a key role in
the conceptualization and discovery of tissue selectivity of
SPRMs". In concluding, he reviewed the various hypothe-
ses concerning the molecular mechanism of action of
these new therapeutic agents and suggested that the tissue
selective effects of SPRMs are controlled by tissue differ-
ences in steroid-receptor coregulators. New research to
explore these aspects of SPRM molecular biology will be
both exciting and important.
Estrogen receptor-alpha (ER-alpha) and defects 
in uterine receptivity in women
Dr. Bruce A. Lessey, M.D., Ph.D., Director, Division of
Reproductive Endocrinology, Center for Women's Medi-
cine, Greenville Hospital Systems, Greenville, South Caro-
lina, continued the emphasis on aberrant endometrial
states with his presentation entitled: "Estrogen receptor-
alpha (ER-alpha) and defects in uterine receptivity in
women". Dr. Lessey provided a novel and interesting
hypothesis, namely, that under progesterone influence
"...the decline in ER-alpha... in the endometrium... may be
a critical event, releasing an inhibitory influence on spe-
cific genes and providing a signal for endometrial recep-
tivity to commence". As an example of a critical gene
inhibited by estrogen action, Dr. Lessey focused on the
alphaV/beta3 integrin, a gene closely associated with suc-
cessful human implantation. During the normal luteal
phase, ER alpha declines and the expression of alphaV/
beta3 increases in the luminal epithelium. But in cases of
luteal phase defect and endometriosis, ER alpha remains
aberrantly high and the alphaV/beta3 integrin gene is not
expressed. Further, estrogen can inhibit beta3 expression
in Ishikawa cells in culture, and this inhibition was
blocked by an antiestrogen, strongly implicating ER alpha
as a key mediator of alphaV/beta3 suppression. Dr. Lessey
suggested that defects in regulation of ER alpha may be at
the root of various defects in uterine receptivity and that...
"the presence of ER-alpha in mid-luteal endometrium
may be the best biomarker of a dysfunctional
endometrium". This novel hypothesis should stimulate a
burst of new research in the field of uterine receptivity.
The role of HLA-G in human pregnancy
Finally, Dr. Joan Hunt, Ph.D., Professor of Anatomy and
Cell Biology, University of Kansas Medical Center, Kansas
City, Kansas, discussed the ultimate endpoint of endome-
trial function, namely, establishment and maintenance of
pregnancy in her overview : "The role of HLA-G in human
pregnancy". She noted that... "The enigma of mammalian
pregnancy, which usually succeeds despite genetic differ-Publish with BioMed Central    and   every 
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ences between the mother and her embryo/fetus, has
intrigued immunologists for half a century." It was Sir
Peter Medawar who stated that the pregnant uterus is an
immune privileged site, and in this review, Dr. Hunt out-
lined the maternal and fetal interactions which underlie
that privileged state. Her main focus was on the molecular
biology of the HLA-G group of antigens, their soluble and
membrane forms, and the evidence for their role in
immune privilege. She pointed out that fetal cytotrophob-
lasts, as they migrate towards the decidua, serially express
different members of the HLA-G family, most likely in
response to changes in oxygen tension gradients. She
summarized the functional evidence that HLA-G antigens
can suppress the immune responses of various hemat-
opoietic cells and concluded that HLA-G molecules are
the key players that regulate immune responses in the
pregnant uterine environment, though other factors may
also play important roles. There are orthologues of the
HLA-G molecular family in nonhuman primates, espe-
cially the Paan-AG gene, which has both similarities to
and differences from human HLA-G genes. Dr. Hunt
noted that further experimental analysis of the role of the
Paan-AG gene family in protecting pregnancy in nonhu-
man primates would greatly improve our understanding
of human semiallogeneic pregnancy.
The symposium was also greatly honored by the attend-
ance of Dr. David T. Baird, Professor, Department of
Obstetrics and Gynecology, Centre for Reproductive Biol-
ogy, University of Edinburgh Edinburgh, UK, who con-
tributed immensely to the program by discussing his
recent work on ovarian folliculogenesis, which will be
published in a separate venue.
In sum, this symposium consisted of a series of brilliant
and exciting presentations from world-renowned author-
ities covering the range of normal and abnormal endome-
trial function, from menstruation to implantation, from
bleeding disorders to endometriosis, and from genomic
profiling to the molecular biology of the HLA-G gene.
There is much here to intrigue and benefit both the avid
student of endocrinology and the busy clinician striving
to improve women's health. Enjoy!
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